BNGO(4h) Technical ChartBionano Genomics, Inc.
Formation: Falling Wedge Pattern
SL-6.56$
TP1-9.63$
TP2-11.65$
−6.6399USD
−232.49 MUSD
36.12 MUSD
60.58 M
About Bionano Genomics, Inc.
Sector
Industry
CEO
Robert Erik Holmlin
Website
Headquarters
San Diego
Employees (FY)
344
Founded
2003
ISIN
US09075F3055
FIGI
BBG001KWWRS9
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of BNGO is 0.7872 USD — it has decreased by 3.51% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Bionano Genomics, Inc. stocks are traded under the ticker BNGO.
Bionano Genomics, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
BNGO stock is 14.78% volatile and has beta coefficient of 4.67. Check out the list of the most volatile stocks — is Bionano Genomics, Inc. there?
One year price forecast for Bionano Genomics, Inc. has a max estimate of 11.0000 USD and a min estimate of 3.0000 USD.
BNGO earnings for the last quarter are −3.22 USD whereas the estimation was −0.97 USD which accounts for −232.07% surprise. Estimated earnings for the next quarter are −0.87 USD. See more details about Bionano Genomics, Inc. earnings.
Bionano Genomics, Inc. revenue for the last quarter amounts to 9.32 M USD despite the estimated figure of 9.08 M USD. In the next quarter revenue is expected to reach 10.55 M USD.
Yes, you can track Bionano Genomics, Inc. financials in yearly and quarterly reports right on TradingView.
BNGO stock has fallen by 26.43% compared to the previous week, the month change is a 23.57% fall, over the last year Bionano Genomics, Inc. has showed a 89.31% decrease.
BNGO net income for the last quarter is −43.89 M USD, while the quarter before that showed −112.57 M USD of net income which accounts for 61.01% change. Track more Bionano Genomics, Inc. financial stats to get the full picture.
Today Bionano Genomics, Inc. has the market capitalization of 49.95 M, it has increased by 6.27% over the last week.
No, BNGO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BNGO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bionano Genomics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 344.00 employees. See our rating of the largest employees — is Bionano Genomics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bionano Genomics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bionano Genomics, Inc. stock shows the sell signal. See more of Bionano Genomics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Bionano Genomics, Inc. future price: according to them, BNGO price has a max estimate of 11.00 USD and a min estimate of 3.00 USD. Read a more detailed Bionano Genomics, Inc. forecast: see what analysts think of Bionano Genomics, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Bionano Genomics, Inc. EBITDA is −116.79 M USD, and current EBITDA margin is −348.10%. See more stats in Bionano Genomics, Inc. financial statements.